Weekend hospitalization linked to longer stay for pediatric leukemia patients

August 25, 2014

Bottom Line: Weekend admission to the hospital for pediatric patients newly diagnosed with leukemia was associated with a longer length of stay, slightly longer wait to start chemotherapy and higher risk for respiratory failure but weekend admissions were not linked to an increased risk for death.

Author: Elizabeth K. Goodman, B.A., of the Children's Hospital of Philadelphia, and colleagues.

Background: Leukemia is a common childhood cancer that accounts for about 30 percent of all pediatric cancer diagnoses. Previous research has indicated an increased risk of death in adults with leukemia whose first admission was on a weekend. But there has been little investigation of weekend admissions for pediatric leukemia patients.

How the Study Was Conducted: The authors examined adverse clinical outcomes associated with a weekend admission for the first hospitalization of pediatric patients newly diagnosed with leukemia. The study from 1999 to 2011 used data from the Pediatric Health Information System database. Participants were children newly diagnosed with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML).

Results: The authors identified 10,720 patients with new-onset ALL and 1,323 with new-onset AML. Of those, 2,009 patients (16.7 percent) were admitted on the weekend. Patients admitted on the weekend did not have an increased rate of mortality during their first hospitalization, but they did have an increased length of stay (1.4 day increase), slightly longer time to start chemotherapy (0.36 day increase) and a higher risk for respiratory failure.

Discussion: "Given the increasing need for cost-effective care in medically complex children, these findings highlight a potential area for improvement in patient care and in cost reduction. Hospitals should consider the increased acuity level of index admissions of pediatric patients with leukemia when determining allocation of weekend staff and clinical resources. Optimizing weekend resources may not only help to reduce hospital LOS (length of stay) across all weekend admissions but may also ensure the availability of comprehensive care for those weekend admissions with higher acuity."

(JAMA Pediatr. Published online August 25, 2014. doi:10.1001/jamapediatrics.2014.1023. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: An author made a conflict of interest disclosure. This study was supported by a grant from the National Institutes of Health and by grant sponsor Hematologic Research Malignancies Fund at the Children's Hospital of Philadelphia. Please see article for additional information, including other authors, author contributions and affiliations, etc.

Editorial: Weekend Hospitalization

In a related editorial, Patrick J. Hagan, M.H.S.A., an independent consultant and former president and chief operating officer of the Seattle Children's Hospital, writes: "In this issue of JAMA Pediatrics, Goodman and colleagues have provided a good service for patients, clinicians and hospital leaders by demonstrating a statistically significant difference in hospital performance for patients admitted on weekends vs. weekdays."

"The authors noted that for index leukemia cases, a higher proportion of higher-acuity patients can be expected on weekends. They suggest that changes in staffing levels and staff skill mix in anticipation of this higher-acuity patient may prove beneficial," Hagan notes.

(JAMA Pediatr. Published online August 25, 2014. doi:10.1001/jamapediatrics.2014.1531. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see article for additional information, including other authors, author contributions and affiliations, etc.
Media Advisory: To contact author Elizabeth K. Goodman, B.A., call Rachel Salis-Silverman at 267-426-6063 or email salis@email.chop.edu. To contact editorial author Patrick J. Hagan, M.H.S.A., email phagan.hagan@gmail.com.

To place an electronic embedded link to this study in your story The links for this study and editorial will be live at the embargo time: http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2014.1023 and http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2014.1531.

The JAMA Network Journals

Related Leukemia Articles from Brightsurf:

New therapeutic approach against leukemia
Using an RNA molecule complex, researchers can prevent retention of cancer stem cell in their tumor supporting niche

Nanoparticle for overcoming leukemia treatment resistance
One of the largest problems with cancer treatment is the development of resistance to anticancer therapies.

Key gene in leukemia discovered
Acute myeloid leukemia (AML) is one of the most common forms of blood cancer among adults and is associated with a low survival rate, and leads to the inhibition of normal blood formation.

Vitamin B6, leukemia's deadly addiction
Researchers from CSHL and Memorial Sloan Kettering Cancer Center have discovered how Acute Myeloid Leukemia is addicted to vitamin B6.

Artificial intelligence tracks down leukemia
Artificial intelligence can detect one of the most common forms of blood cancer - acute myeloid leukemia -- with high reliability.

Milestone reached in new leukemia drug
Using a chemical compound called YKL-05-099, a team of cancer researchers from CSHL and the Dana Farber Institute was able to target the Salt-Inducible Kinase 3 (SIK3) pathway and extend survival in mice with MLL leukemia.

The drug combination effective against bovine leukemia
Scientists have succeeded in reducing levels of the bovine leukemia virus (BLV) in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor.

Towards a safer treatment for leukemia
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the Children's Cancer Institute, Australia, have found a safer treatment for a specific type of leukemia.

Research paves way for new source for leukemia drug
Chemistry researchers have patented a method for making anti-leukemia compounds that until now have only been available via an Asian tree that produces them.

An atlas of an aggressive leukemia
A team of researchers led by Bradley Bernstein at the Ludwig Center at Harvard has used single-cell technologies and machine learning to create a detailed 'atlas of cell states' for acute myeloid leukemia (AML) that could help improve treatment of the aggressive cancer.

Read More: Leukemia News and Leukemia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.